- Conditions
- Ischemic Stroke
- Interventions
- Verapamil
- Drug
- Lead sponsor
- Justin Fraser
- Other
- Eligibility
- 21 Years to 85 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Acute Ischemic Stroke
- Interventions
- Ketamine, Normal Saline, Midazolam injection
- Drug · Other
- Lead sponsor
- Lower Merion Neurology Research Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Wynnewood, Pennsylvania
- Conditions
- Hypoxic-ischemic Encephalopathy
- Interventions
- erythropoietin
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- Up to 24 Hours
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Traumatic Brain Injury
- Interventions
- Memantine, Placebo
- Drug
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Stress Response, Mental Stress, Multitasking Behavior and Multitasking Ability, Physiological Stress, Cognitive Symptoms, Motor Activity
- Interventions
- Cranberry juice, Placebo juice
- Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 30 Years to 55 Years
- Enrollment
- 84 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Stroke, Acute, Ischemic Stroke, Hemorrhagic Stroke, Mortality, Morbidity
- Interventions
- Minocycline
- Drug
- Lead sponsor
- Maimonides Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Brooklyn, New York
- Conditions
- Aortic Valve Stenosis, Aortic Stenosis, Aortic Valve Disease
- Interventions
- EmStop Embolic Protection System, Boston Scientific Sentinel
- Device
- Lead sponsor
- EmStop Inc
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 663 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 3
- States / cities
- New Orleans, Louisiana • Asheville, North Carolina • Rapid City, South Dakota
- Conditions
- Aneurysmal Subarachnoid Hemorrhage
- Interventions
- Tiopronin, Placebo
- Drug
- Lead sponsor
- E. Sander Connolly
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 3
- States / cities
- Gainesville, Florida • New York, New York • Seattle, Washington
- Conditions
- Alzheimer's Disease
- Interventions
- BMS-984923, Placebo
- Drug
- Lead sponsor
- Allyx Therapeutics
- Industry
- Eligibility
- 50 Years to 80 Years
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- New Haven, Connecticut • West Bend, Wisconsin
- Conditions
- Open Angle Glaucoma, Primary Open Angle Glaucoma, Low Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma
- Interventions
- EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month), Vehicle Placebo
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Ischemic Stroke
- Interventions
- Albumin, Saline
- Biological · Drug
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years to 83 Years
- Enrollment
- 841 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2013
- U.S. locations
- 69
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Concord, California + 48 more
- Conditions
- Glaucoma, Primary Open Angle
- Interventions
- NT-501 CNTF Implant
- Drug
- Lead sponsor
- Jeffrey L Goldberg
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Brain Injuries, Head Injury, Brain Concussion
- Interventions
- magnesium sulfate
- Drug
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 14 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2005
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Malignant Glioma
- Interventions
- Hydrogen, Placebo oral tablet
- Drug
- Lead sponsor
- Stony Brook University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2027
- U.S. locations
- 1
- States / cities
- Stony Brook, New York
- Conditions
- Cardiac Arrest, Return of Spontaneous Circulation
- Interventions
- Magnesium Sulfate, Saline
- Drug
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 178 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Optic Atrophy, Non-arteritic Anterior Ischemic Optic Neuropathy
- Interventions
- QPI-1007 at various doses
- Drug
- Lead sponsor
- Quark Pharmaceuticals
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 22
- States / cities
- Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 19 more
- Conditions
- Stroke, Ischemic
- Interventions
- Intra-arterial cold saline, minocycline, and magnesium
- Drug
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 18 Years to 90 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Manhasset, New York
- Conditions
- Alzheimer Disease, Dementia, Healthy Participants, Brain Health
- Interventions
- Brain Health Education, Alzheimer Disease Education
- Behavioral
- Lead sponsor
- Retain Health, Inc
- Other
- Eligibility
- 53 Years to 105 Years
- Enrollment
- 992 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Bedford, Massachusetts
- Conditions
- Cerebrovascular Accident
- Interventions
- Magnesium Sulfate, Normal Saline
- Drug
- Lead sponsor
- Jeffrey L. Saver
- Other
- Eligibility
- 40 Years to 95 Years
- Enrollment
- 1,700 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2013
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Prematurity, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage, Periventricular Leukomalacia
- Interventions
- inhaled nitric oxide, oxygen
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 2 Hours to 72 Hours
- Enrollment
- 273 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2023
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Down Syndrome, Mild Cognitive Impairment
- Interventions
- Low Dose Nicotine (7mg), Moderate Dose Nicotine (14mg)
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 25 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2021
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Cognitive Decline
- Interventions
- Lidocaine, Placebo
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 550 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2017
- U.S. locations
- 2
- States / cities
- Durham, North Carolina • Norfolk, Virginia
- Conditions
- Neurocognitive, Neuroprotective, Neonatal, Neurodevelopmental Impairment
- Interventions
- Darbepoetin, Placebo
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 650 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • Palo Alto, California • Atlanta, Georgia + 12 more
- Conditions
- Ischemic Stroke
- Interventions
- Verapamil and Citicoline, Placebo
- Drug · Other
- Lead sponsor
- Justin Fraser
- Other
- Eligibility
- 18 Years to 101 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky